Structural and Biochemical Insights into the Arabinose and Xylose Derivatives of Cyclic-GAMP-Mediated Inhibition of Mycobacterium tuberculosis Cyclic-di-AMP Phosphodiesterase
Biochemistry · 04.08.2026 · 65 (15) · 2441-2451
DOI: 10.1021/acs.biochem.6c00106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, online erschienen am 28.05.2026. Verfasst von Dagur Singh Hanuman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Macromolecular Structural Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Hyderabad (IITH), Hyderabad, Telangana50228…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Arabinose, Xylose, Nucleotides, Cyclic. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Bacterial infection, including that ofMycobacterium tuberculosis, leads to the accumulation of the bacterial cyclic dinucleotides (CDN), c-di-AMP and c-di-GMP, and the host cGAMP synthase-catalyzed CDN, 2′3′-cGAMP in the cytosol, which activates STING-dependent type I interferon (IFN) and NF-κB immune responses. The mycobacterial cyclic dinucleotide phosphodiesterase (CdnP) secreted into the host macrophages blunts host immunity by directly cleaving bacterial- and host-derived CDNs. The arabinose- and xylose-modified 2′3′-cGAMP (2′3′-(A/X)cGAMP) analogues act as potent STING agonists and resist hydrolysis by the host-PDE ENPP1. Here, we report that 2′3′-(A/X)-cGAMP analogues bind to CdnP and compete with its substrate binding. Further studies revealed that these analogues inhibit the catalytic activity of CdnP. The cocrystal structure demonstrates that the arabinose-derived 2′3′-cGAMP (AR-cGAMP) analogue is trapped in an unusual U-shaped conformation in the substrate-binding pocket, away from the catalytic residue and Mn2+, which suggests that CdnP is incompetent to hydrolyze the analogue and cannot accept the other CDN substrate for hydrolysis. Given that several bacterial and viral pathogens deploy CDN phosphodiesterase enzymes to hydrolyze both host and pathogen-derived STING agonists, sugar-modified CDNs can be used to weaken bacterial and viral defenses and stimulate the STING-mediated host immunity against these pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Macromolecular Structural Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Hyderabad (IITH), Hyderabad, Telangana502285, India.
- Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York10065, United States.
- Amity Institute of Biotechnology, Amity University Haryana, Haryana122413, India.
ORCID-Profile: Suman Abhishek, Eerappa Rajakumara
Förderung
- Science and Engineering Research Board
Zitieren
APA
Hanuman, D. S., Neeharika, S., Nitin, K., Abhishek, S., Sinha, K. M., & Rajakumara, E. (2026). Structural and Biochemical Insights into the Arabinose and Xylose Derivatives of Cyclic-GAMP-Mediated Inhibition of Mycobacterium tuberculosis Cyclic-di-AMP Phosphodiesterase. Biochemistry, 65(15), 2441-2451. https://doi.org/10.1021/acs.biochem.6c00106
Vancouver
Hanuman DS, Neeharika S, Nitin K, Abhishek S, Sinha KM, Rajakumara E. Structural and Biochemical Insights into the Arabinose and Xylose Derivatives of Cyclic-GAMP-Mediated Inhibition of Mycobacterium tuberculosis Cyclic-di-AMP Phosphodiesterase. Biochemistry. 2026;65(15):2441-2451. doi:10.1021/acs.biochem.6c00106
BibTeX
@article{Hanuman2026,
author = {Hanuman, Dagur Singh and Neeharika, Singh and Nitin, Kulhar and Abhishek, Suman and Sinha, Krishna Murari and Rajakumara, Eerappa},
title = {Structural and Biochemical Insights into the Arabinose and Xylose Derivatives of Cyclic-GAMP-Mediated Inhibition of Mycobacterium tuberculosis Cyclic-di-AMP Phosphodiesterase},
journal = {Biochemistry},
year = {2026},
volume = {65},
number = {15},
pages = {2441--2451},
doi = {10.1021/acs.biochem.6c00106}
}
EUVIMED